Who owns iShares U.S. Pharmaceuticals ETF?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of IHE from SEC Form 13F filings across 209 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 209 institutions disclosed 7.3M shares of iShares U.S. Pharmaceuticals ETF worth $727.4M — about 64.9% of shares outstanding; the largest disclosed holder is Fisher Asset Management, LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
209
13F holders
$727.4M
value, 2026 filers
64.9%
of shares outstanding (7.3M sh)
39
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of IHE's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Fisher Asset Management, LLC | 2.7M | $270.6M | 0.1% | 24.1% | -1.2% |
| 2 | BANK OF AMERICA CORP /DE/ | 862,713 | $85.4M | 0.0% | 7.6% | +88.9% |
| 3 | JPMORGAN CHASE & CO | 553,812 | $55.5M | 0.0% | 4.9% | +47.4% |
| 4 | MORGAN STANLEY | 457,623 | $45.3M | 0.0% | 4% | -4.7% |
| 5 | LPL Financial LLC | 230,925 | $22.9M | 0.0% | 2% | +35.7% |
| 6 | TD Asset Management IncNEW | 192,500 | $19.1M | 0.0% | 1.7% | new |
| 7 | Mirae Asset Global Investments Co., Ltd.NEW | 190,000 | $18.8M | 0.0% | 1.7% | new |
| 8 | GOLDMAN SACHS GROUP INC | 185,841 | $18.4M | 0.0% | 1.6% | +132.6% |
| 9 | ROYAL BANK OF CANADA | 135,148 | $13.4M | 0.0% | 1.2% | +16.2% |
| 10 | Insight Wealth Strategies, LLC | 122,642 | $12.1M | 1.2% | 1.1% | +3.3% |
| 11 | UBS Group AG | 110,100 | $10.9M | 0.0% | 1% | +177.5% |
| 12 | WELLS FARGO & COMPANY/MN | 75,451 | $7.5M | 0.0% | 0.7% | +7.9% |
| 13 | BROWN ADVISORY INC | 75,432 | $7.5M | 0.0% | 0.7% | 0.0% |
| 14 | RAYMOND JAMES FINANCIAL INC | 71,836 | $7.1M | 0.0% | 0.6% | +7.6% |
| 15 | Monument Capital ManagementNEW | 60,787 | $6.0M | 1.2% | 0.5% | new |
| 16 | BNP PARIBAS FINANCIAL MARKETS | 52,491 | $5.2M | 0.0% | 0.5% | -1.5% |
| 17 | Concurrent Investment Advisors, LLC | 52,448 | $5.2M | 0.0% | 0.5% | -8.3% |
| 18 | Concord Investment Counsel Inc. | 49,456 | $4.9M | 1.3% | 0.4% | +0.6% |
| 19 | Accurate Wealth Management, LLCNEW | 47,786 | $4.8M | 0.5% | 0.4% | new |
| 20 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 43,401 | $4.3M | 0.0% | 0.4% | -28.1% |
| 21 | AMERIPRISE FINANCIAL INC | 41,731 | $4.1M | 0.0% | 0.4% | -10.9% |
| 22 | Tidal Investments LLCNEW | 37,534 | $3.7M | 0.0% | 0.3% | new |
| 23 | FFG Partners, LLC | 35,599 | $3.5M | 1.0% | 0.3% | +887.5% |
| 24 | Beacon Pointe Advisors, LLC | 35,469 | $3.5M | 0.0% | 0.3% | -3.3% |
| 25 | Merit Financial Group, LLC | 31,245 | $3.1M | 0.0% | 0.3% | -0.2% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.